A randomized, double-blind, placebo-controlled, phase II

Project: Research project

Project Details

Description

A randomized, double-blind, placebo-controlled, phase II study to assess the efficacy and safety of oral vismodegib for the treatment of basal cell carcinoma preceding excision by Mohs micrographic surgery
StatusFinished
Effective start/end date10/23/1312/31/15

Funding

  • Genentech Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.